Susquehanna Fundamental Investments’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Susquehanna Fundamental Investments's AMGN Position: Q1 2026 in Review
Susquehanna Fundamental Investments sold out of Amgen (AMGN) in Q1 2026, closing a stake of 30,566 shares — an estimated $10M sold.
Susquehanna Fundamental Investments first reported a position in AMGN in Q1 2018 and held it in 26 quarters. The position peaked at $43.3M in Q1 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Susquehanna Fundamental Investments reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
- Susquehanna Fundamental Investments sold 30,566 Amgen shares in Q1 2026, an estimated $10M.
- Susquehanna Fundamental Investments first reported a position in Amgen in Q1 2018 and held it in 26 quarters.
- Susquehanna Fundamental Investments's Amgen position peaked at $43.3M in Q1 2025.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Susquehanna Fundamental Investments's 13F filing for Q1 2026, filed 15 May 2026.